Source: Critical care medicine. Unidade: FM
Subjects: SÍNDROME DO DESCONFORTO RESPIRATÓRIO EM ADULTOS, PNEUMONIA, CÉLULAS ESTROMAIS, FATORES DE CRESCIMENTO, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Johnatas D. e CAPELOZZI, Vera Luiza. Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome. Critical care medicine, v. 46, n. 2, p. E132-E140, 2018Tradução . . Disponível em: https://doi.org/10.1097/CCM.0000000000002833. Acesso em: 26 set. 2024.APA
Silva, J. D., & Capelozzi, V. L. (2018). Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome. Critical care medicine, 46( 2), E132-E140. doi:10.1097/CCM.0000000000002833NLM
Silva JD, Capelozzi VL. Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome [Internet]. Critical care medicine. 2018 ; 46( 2): E132-E140.[citado 2024 set. 26 ] Available from: https://doi.org/10.1097/CCM.0000000000002833Vancouver
Silva JD, Capelozzi VL. Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome [Internet]. Critical care medicine. 2018 ; 46( 2): E132-E140.[citado 2024 set. 26 ] Available from: https://doi.org/10.1097/CCM.0000000000002833
